Every aspect of the best clinical care that exists today starts with the same process: Clinical research that ensures medical advances are ethically sound, safe and effective.
More clinical research takes place at the Texas Medical Center than at any other campus in the world. We take pride in the clinical research that has been a bedrock of this medical city for 70 years, and it’s the reason we attract the world’s top scientists and clinicians. The best clinical care is found adjacent to the leading research programs, as scientists and clinicians are constantly searching for the best solutions for their patients. Often, the most advanced therapy may only be available as part of a clinical trial, so it is important to patients and their families to have access to all treatment alternatives.
But clinical research here has a big challenge: It can be exhausting, expensive work managing the bureaucracy and legalities involved. Today, if industry has a promising new medical device or therapy and wants all 10 million patients at the Texas Medical Center to have access to it, it would take upwards of two years to sign all the necessary paperwork at each of the 29 institutions here that conduct clinical research.
Our new TMC Clinical Research Institute, which debuts in 2018, will change all of that.
The institute will create a unified, streamlined interface to industry. Companies can sign one set of documents that will be supported by all of our research institutions. Once we establish our unified processes, the Texas Medical Center will immediately become the largest, most efficient multi-institutional clinical research platform in the world. The new institute will not only complement individual research programs, but will also provide researchers and patients access to multi- institution trials, further elevating all programs.
Back in 2014, when all of the CEOs and leaders of the Texas Medical Center formulated the TMC Strategic Plan, clinical research emerged as a leading opportunity. After working doggedly to refine the concept, we finally have the infrastructure to bring it to reality.
Major industry leaders are already lining up in anticipation of the TMC Clinical Research Institute launch. It’s yet another example of the way collaboration allows us to transcend our individual capabilities and advance the care of our patients.
@latinaggie Thank you for taking time out of your day to share a comment with us. Due to federal privacy laws, we cannot respond further via social media. However, we would like to discuss this issue with you. Please call 713.441.4100 or visit https://t.co/wPtazimDiv . - Sandra
U.S. Marines Sgt. Jake Wood, Co-Founder and CEO of @TeamRubicon, to Receive Pat Tillman Award for Service at The 2018 ESPYS https://t.co/CNq0pCH1lf via @TaraESPN
RT @harrishealth: It's hot out there, Houston! #Heat illnesses can be a serious concern during the #summer. Learn how to recognize the sign…
RT @BCMHouston_News: Study led by @bcmhouston @BCMCancer's Dr. Nangia validates the safety and effectiveness of scalp cooling therapy to pr…
@AgriLifeDallas @txextension @txresearch @AgriLifeWaterU @TAMU @aglifesciences Thanks for sharing ^SF
@SurgicalTheater Thanks for the shout-out ^SF
Harris Health System@harrishealth
It's hot out there, Houston! #Heat illnesses can be a serious concern during the #summer. Learn how to recognize the sign and symptoms for heat cramps, heat exhaustion and heat stroke. Stay hydrated! https://t.co/WgF5TCjGxd https://t.co/p0zEIl19Br
7 questions to ask yourself when considering a #clinicaltrial: https://t.co/w5noDYHoEv #endcancer
Most of the time manicures make your nails look better, but sometimes it can lead to an allergic reaction. https://t.co/W77MRjq2uz
Whether eating on the go or at your desk, what are your favorite healthy snacks? https://t.co/bvJtj11ZO2
RT @fondrenlibrary: We're partnering with @houstonlibrary @harriscountypl and @UHoustonLib to create the @HarveyMemories project. Browse an…
RT @MDAndersonTrial: A Phase I, Open-Label, Dose Escalation and Cohort Expansion Study Evaluating the Safety, Pharmacokinetics (PK), Pharma…
RT @MDAndersonTrial: Volatile Anaesthesia and Perioperative Outcomes Related to Cancer (VAPOR-C): A Feasibility Study now Enrolling https:/…
CHI St. Luke's Health@CHI_StLukes
Baylor St. Luke’s Medical Center is the first hospital in the country to take part in Cerus’ RedeS study, a transfusion therapy trial for an innovative technology that can reduce transfusion recipients’ risk of infection from #Zika or #WestNileVirus. https://t.co/BQaCnjizEO https://t.co/s61jNkGMAu
RT @fondrenlibrary: In honor of #MandelaDay, here's a link to a @BakerInstitute Report describing Mandela's address @RiceUniversity in Octo…